ArticleBMC genomics2025
Genomic evolution and stability of the mcr-1-harboring IncI2 plasmid in the presence and absence of colistin.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of plasmid-mediated colistin resistance, primarily driven by the mcr-1 gene, represents a major global health threat. IncI2 plasmids, one of the leading carriers of mcr-1, have been frequently recovered from clinical and agricultural settings. However, their persistence in the absence of antibiotic pressure and adaptive responses to colistin exposure remain poorly understood.
methodsWe conducted 60-day laboratory evolution experiments using Escherichia coli C600 carrying the mcr-1-harboring IncI2 plasmid pBD110 under three colistin concentrations (0, 2, and 4 mg/L). Stability was evaluated using polymerase chain reaction (PCR). Bacterial fitness was assessed using growth curve analysis and competition assays. Antimicrobial susceptibility was determined by the broth microdilution method. Conjugation potential was examined using conjugation experiments. Genomic alterations were investigated using whole-genome sequencing combined with bioinformatic analysis.
resultspBD110 was stably maintained for 120 passages under all conditions, with no significant loss observed in the absence of colistin. Under strong selection (4 mg/L), plasmid abundance increased, whereas moderate pressure (2 mg/L) led to fitness costs and reduced plasmid copy number. Whole-genome sequencing revealed distinct adaptive strategies: plasmids under non-selective conditions accumulated mutations in conjugation-related genes, enhancing transfer frequency, whereas those under colistin exposure retained structural stability but acquired shufflon inversions that impaired conjugation. Host genomes accumulated numerous chromosomal mutations, particularly in metabolic and stress response pathways, to compensate for resistance-associated burdens.
conclusionsIncI2 plasmids exhibit dual evolutionary strategies. In the absence of colistin, they optimized horizontal transfer, whereas under selective pressure, they prioritized the stability and vertical inheritance of mcr-1. These findings provide new insights into the persistence and dissemination of colistin resistance and highlight evolutionary trade-offs that shape plasmid-host coadaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.